MedTrace Logo

CERAMENT G as Part of the Surgical Treatment of Osteomyelitis in a Single-Stage Procedure

NCT06555848 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 128

Last updated 2026-05-04

No results posted yet for this study

Summary

The study is a prospective cohort study of subjects where CERAMENT G was used as part of the surgical treatment of osteomyelitis in a single stage procedure.

Conditions

  • Osteomyelitis

Interventions

DEVICE

CERAMENT G

CERAMENT G is intended for use as a bone void filler as an adjunct to systemic antibiotic therapy and surgical debridement (standard treatment approach to a bone infection) as part of the surgical treatment of osteomyelitis. By eluting gentamicin, CERAMENT G can reduce the recurrence of chronic osteomyelitis from gentamicin-sensitive microorganisms in order to protect bone healing.

Sponsors & Collaborators

  • BONESUPPORT AB

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-02
Primary Completion
2031-10-31
Completion
2032-10-31
FDA Device
Yes

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06555848 on ClinicalTrials.gov